Baker Avenue Asset Management, LP Cardiol Therapeutics Inc. Put Options Transaction History
Baker Avenue Asset Management, LP
- $5.03 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CRDL
# of Institutions
45Shares Held
6.11MCall Options Held
37.6KPut Options Held
0-
Tejara Capital LTD London, X02.63MShares$2.76 Million1.47% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD857KShares$900,2570.22% of portfolio
-
Lion Street Advisors, LLC340KShares$357,0260.15% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9293KShares$307,7080.15% of portfolio
-
Pvg Asset Management Corp Golden, CO283KShares$297,6451.46% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $65M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...